NDC 15631-0253

KALI PHOSPHORICUM

Kali Phosphoricum

KALI PHOSPHORICUM is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Potassium Phosphate, Dibasic.

Product ID15631-0253_7d9ceace-7781-40cf-b686-7b64c7ee97ab
NDC15631-0253
Product TypeHuman Otc Drug
Proprietary NameKALI PHOSPHORICUM
Generic NameKali Phosphoricum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-09-05
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NamePOTASSIUM PHOSPHATE, DIBASIC
Active Ingredient Strength1 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0253-0

100 PELLET in 1 PACKAGE (15631-0253-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0253-1 [15631025301]

KALI PHOSPHORICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0253-4 [15631025304]

KALI PHOSPHORICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0253-5 [15631025305]

KALI PHOSPHORICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0253-0 [15631025300]

KALI PHOSPHORICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0253-3 [15631025303]

KALI PHOSPHORICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

NDC 15631-0253-2 [15631025302]

KALI PHOSPHORICUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-23

Drug Details

Active Ingredients

IngredientStrength
POTASSIUM PHOSPHATE, DIBASIC1 [hp_X]/1

OpenFDA Data

SPL SET ID:074959bb-0638-4e60-bdd2-2880d3fd382c
Manufacturer
UNII

NDC Crossover Matching brand name "KALI PHOSPHORICUM" or generic name "Kali Phosphoricum"

NDCBrand NameGeneric Name
0220-2908Kali phosphoricumPOTASSIUM PHOSPHATE, DIBASIC
0220-2962Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
0220-2963Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
0220-2964Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
0220-2965Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
0220-2966Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
0220-2967Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
0220-2968Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
0220-2969Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
0220-2970Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
0360-0237KALI PHOSPHORICUMKALI PHOS
0360-0239KALI PHOSPHORICUMKALI PHOS
15631-0253KALI PHOSPHORICUMKALI PHOSPHORICUM
15631-0612KALI PHOSPHORICUMKALI PHOSPHORICUM
37662-1732Kali PhosphoricumKali Phosphoricum
37662-1733Kali PhosphoricumKali Phosphoricum
37662-1734Kali PhosphoricumKali Phosphoricum
37662-1735Kali PhosphoricumKali Phosphoricum
37662-1736Kali PhosphoricumKali Phosphoricum
37662-1737Kali PhosphoricumKali Phosphoricum
37662-1738Kali PhosphoricumKali Phosphoricum
37662-1739Kali PhosphoricumKali Phosphoricum
37662-1740Kali PhosphoricumKali Phosphoricum
60512-8021KALI PHOSPHORICUMKALI PHOSPHORICUM
60512-8022KALI PHOSPHORICUMKALI PHOSPHORICUM
62106-5107KALI PHOSPHORICUMPotassium dihydrogen phosphate
63083-8006Kali PhosphoricumKali Phosphoricum
63545-660Kali PhosphoricumKali Phosphoricum
68428-456Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
71753-8006Kali PhosphoricumKali Phosphoricum
71919-387Kali phosphoricumDIBASIC POTASSIUM PHOSPHATE
71919-746KALI PHOSPHORICUMDIBASIC POTASSIUM PHOSPHATE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.